A soil isolate of actinomycete, strain SANK 60684, was found to produce new enkephalinase B inhibitors, propioxatins A and B. The presence of both LL-and meso-2,6-diaminopimelic acid, glycine and galactose in the cell wall assigned this strain to genus Kitasatosporia.
From the morphological, cultural and physiological characteristics, this strain was determined to be Kitasatosporia setae.
The Ki values of propioxatins A and B were 1.3 x 10-y M and 1.1 x 10-7 M, respectively, for enkephalinase B. All other proteases examined except aminopeptidases, which were slightly inhibited, were not inhibited by these two compounds.
In the course of our extensive screening program for new enkephalinase B inhibitors, we obtained new substances, propioxatins A and B, from the culture broth of a soil isolate.
Enkephalins (Met-enkephalin and Leu-enkephalin) are generally short-lived molecules, being rapidly degraded into inactive derivatives. Therefore, their analgesic function cannot be expected to persist long after administration1). This degradation system in the brain includes aminopeptidases existing in the soluble fraction and the membrane 2-5), enkephalinase A6,7) and enkephalinase By8.
Aminopeptidases hydrolyze the Tyr-Gly bond and release Tyr, enkephalinase A hydrolyzes the GlyPhe bond and releases Tyr-Gly-Gly, and enkephalinase B hydrolyzes the Gly-Gly bond and releases Tyr-Gly. An enkephalinase inhibitor would be expected to act as an analgesic because of the protection of enkephalin degradation in vivo. Some synthetic enkephalinase A inhibitors such as thiorphan9) have been studied but specific inhibitors for enkephalinase B have not been found. Thus, we searched for an enkephalinase B inhibitor in culture filtrates of microorganisms and found two new inhibitors, which consisted of L-prolyl-L-valine peptide with N-acyl containing hydroxamic acid at the N-terminal end. We named these two inhibitors propioxatins A and B. In this paper, we report on the taxonomy of the producing organism, fermentation, isolation and biological properties of propioxatins A and B.
Materials and Methods

Taxonomic Studies
The strain, SANK 60684, was isolated from soil sample collected in Kanagawa prefecture, Japan. Chemical analyses of strain SANK 60684 were performed in terms of cell wall type 12), whole cell sugar pattern13), acyl-type in cell wall14) and mycolic acid15).
Fermentation
The seed medium and production medium (pH 7.2) contained glucose 3 %, soy bean meal 3 %, pressed yeast 1%, CaCO3 0.4% and MgSO4 • 7H20 0.2 % in tap water. A loopful amount of mycelium of an agar culture was incubated to 500 ml of the medium in a 2 liter-flask and shake-cultured for 4 days at 28°C. Fermentation was carried out in two 30-liter jar fermentors containing 15 liters of the medium. After inoculation of 250 ml of the seed culture, the fermentation was continued at 28°C for 4 days with agitation (150 rpm) and aeration (15 liters/minute). The culture broths were filtrated with Hyflo Super-Cel. Isolation and Purification of Propioxatins A and B
A culture filtrate (28 liters) was passed through a column of Diaion HP-20 (5.6 liters bed volume) and washed with distilled water. The propioxatins A and B were eluted with 24 liters of 50% aq EtOH and the eluate was coned under reduced pressure to 2 liters. After the pH was adjusted to 2.0, propioxatins A and B were extracted with equal volume of butanol. The extract was adjusted to pH 7.0 and propioxatins A and B were re-extracted with 2 liters of distilled water. The solution was diluted with 10 mm of AcOH to 10 liters and applied to a DEAE-Sephadex A-25 column (4.5 x 35 cm) previously equilibrated with 10 mm AcOH. After the column was washed with the same solution, propioxatins A and B were eluted with a linear gradient from 10 mm (2.5 liters) to I M AcOH (2.5 liters). The active fractions were pooled and lyophilized. The crude powder (700 mg) was dissolved in 50 ml of 10 mm of AcOH and applied to a DEAE-Toyopearl 650S column (2.2 x 28 cm) previously equilibrated with 10 mm AcOH. After the column was washed with the same solution, propioxatins A and B were eluted with a linear gradient from 10 mm (500 ml) to 1 M AcOH (500 ml). The active fractions were pooled and lyophilized. The crude powder (300 mg) was dissolved with 0. . DEAE-Sephacel chromatography of solubilized rat brain membrane. The dialyzed crude extract was applied to a column (3.5 x 35 cm) previously equilibrated with 5 mm sodium phosphate buffer, pH 7.0, containing 1 % Triton X-100.
After the column was washed with the same buffer, enzymes were eluted with linear sodium chloride gradient of 0 (2.5 liters) to 0.4 M (2.5 liters) (------) in the same buffer and fractions of 20 ml were collected. Aliquots of each fraction were assayed for enkephalin degrading enzyme activity (50 ,eel) and determined for protein concentration (®) (100 ILl). Nano mols of Tyr (C), Tyr-Gly (i) and Tyr-Gly-Gly (0) were indicated. system with Met-enkephalin as a substrate in order to obtain enkephalin degrading enzyme inhibitors. A 100 pl amount of a reaction mixture containing 1 mm Met-enkephalin, enzyme preparation and 0.1 M sodium phosphate buffer, pH 7.0, was incubated at 37°C for 15 minutes and the reaction was stopped by adding 10 µl of 2 N HC1. A 20 izl portion of the mixture was applied to a Develosil ODS-5 column (4.6 x 250 mm) to identify the reaction products, Tyr, Tyr-Gly and Tyr-Gly-Gly. Elution was carried out at 25°C with a 10 mm potassium phosphate -MeOH mixture (100 : 5) at a flow rate of 1.0 ml/minute.
The reaction products were monitored with an emission maximum at 304 nm of Tyr on excitation at 275 nm using a Shimadzu RF-530 fluorescence spectromonitor. Elution times of Tyr, Tyr-Gly and Tyr-Gly-Gly were 4.5, 6.6 and 6.2 minutes, respectively. The amount of the products eluted were calculated with known concentrations of standard samples of Tyr, Tyr-Gly and Tyr-Gly-Gly.
Preparation
and Separation of Membrane-bound Enkephalin Degrading Enzymes Preparation and separation of crude enzymes from rat brain membrane were carried out according to a method of GORENSTEIN and SNYDER8) with slight modifications.
Brains from young male Wister rats (100 g) were homogenized in 10 volumes of 50 mM Tris-HC1 buffer, pH 7.7, with a Polytron. The homogenate was centrifuged at 50,000 x g for 15 minutes and washed three times with the same buffer.
The membrane pellet was solubilized by resuspension with 5 volumes of 50 mM Tris-HC1 buffer, pH 7.7, containing 1 % Triton X-100 and then incubated at 37°C for 60 minutes. Solubilized enzymes were obtained after centrifugation of the mixture at 100,000 x g for 60 minutes. This Triton-solubilized preparation was thoroughly dialyzed against 5 mm sodium phosphate buffer, pH 7.0, containing I % Triton X-100 and then applied to a DEAE-Sephacel column (3.5 x 35 cm) previously equilibrated with the same buffer. The enzymes were eluted with the same buffer containing a linear gradient of sodium chloride to 0.4 M (2.5 liters +2.5 liters). Fig. 2 shows the elution pattern of enkephalin degrading enzymes. Fractions I and II were used as enkephalinase A-I and -II, and fractions III and V were used as aminopeptidase-I and -II, respectively. Enkephalinase B from fraction IV was further purified as follows: the collected fraction of enkephalinase B was dialyzed thoroughly against 5 mm sodium phosphate THE JOURNAL OF ANTIBIOTICS buffer, pH 7.0, containing 1 % Triton X-100. The dialyzed solution was applied to a DEAEToyopearl 650S column (1.6 x 27 cm) previously equilibrated with the same buffer.
The column was washed with the same buffer and the enzyme was eluted with the buffer containing a linear concentration gradient of sodium chloride to 0.4 M (500 ml +500 ml). The enzyme fractions were collected and used for screening and assay of propioxatins A and B. A cytosolic aminopeptidase from rat brain was prepared from a supernatant obtained by centrifugation at 50,000 x g of a homogenate and partially purified by ammonium sulfate precipitation (30-60% saturation) and Mono Q ion exchange chromatography. The reaction mixture for inhibitory activity contained 80 t1l of enzyme solution in 0.1 M sodium phosphate buffer, pH 6.5 (optimum pH of enkephalinase B), 10 /11 of inhibitor solution and 10 td of 1 mm Met-enkephalin in the same buffer (total volume 100 pl). The reaction was stopped by adding 10 14 of 2 N HCI after incubation at 37°C for 15 minutes.
A 20 td aliquot of reaction product, TyrGly, was analyzed as mentioned above. The reaction was also carried out without inhibitor as a control.
The concentration of the inhibitor required for 50% inhibition (IC50 was calculated using 10 mM Met-enkephalin instead of 1 mm.
Results and Discussion
Taxonomic Studies of Strain SANK 60684
Mature spore chains produced in the aerial mycelium were long, with 10 to 50 or more spores per chain. The morphology of the spore chains was determined as Rectiflexibiles, as shown in Plate 1.
The spores were 0.4-0.8 by 0.8-3.0 tim in size with a smooth surface, as shown in Plate 2.
The cultural characteristics of strain SANK 60684 on various media are shown in Table 1 . Physiological properties and carbohydrate utilization are summarized in Tables 2 and 3 , respectively. The cell wall of strain SANK 60684 contained both mesoand LL-2,6-diaminopimelic acid (molecular ratio, 2 : 1) as the diamino acid and glycine. Galactose was detected in whole-organism hydrolysates. The structure determination is described in a subsequent paper. Table 4 . Aminopeptidases were also inhibited by both propioxatins A and B but these activities were over 10-fold lower than for enkephalinase B. Inhibitory activities of propioxatins A and B for other proteases and peptidases are also shown in Table 5 as IC50 values.
Leu-aminopeptidase and aminopeptidase M were inhibited but others were not. The propioxatins were specific inhibitor for enkephalinase B, with propioxatin A being more specific than propioxatin B.
